Chandra Bhagat Pharma Limited has confirmed its exemption from certain corporate governance provisions.

The company is not required to comply with these specific regulations because its securities are listed on the SME Exchange.

Consequently, Chandra Bhagat Pharma will not be submitting a Corporate Governance Report for the quarter ended June 30, 2026. This streamlined compliance process is typical for companies on the SME platform, impacting their reporting structure and public disclosures to investors.